ES2178657T3 - Derivados lipopeptidos, procedimiento para su preparacion y su empleo. - Google Patents

Derivados lipopeptidos, procedimiento para su preparacion y su empleo.

Info

Publication number
ES2178657T3
ES2178657T3 ES95104376T ES95104376T ES2178657T3 ES 2178657 T3 ES2178657 T3 ES 2178657T3 ES 95104376 T ES95104376 T ES 95104376T ES 95104376 T ES95104376 T ES 95104376T ES 2178657 T3 ES2178657 T3 ES 2178657T3
Authority
ES
Spain
Prior art keywords
lipopeptide
employment
procedure
preparation
sub
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95104376T
Other languages
English (en)
Inventor
Rudolf Dr Lattrell
Theodor Dr Wollmann
Holger Dr Wallmeier
Peter Dr Hammann
Dieter Dr Isert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Application granted granted Critical
Publication of ES2178657T3 publication Critical patent/ES2178657T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

DERIVADO LIPOPEPTIDO DE LA FORMULA I DON R 1 IGUAL A OH O NH{SUB,2} Y R{SUP,2} ES UN RESTO C{SUB,8} - C{SUB,22} - ACILO, PREPARADOS FARMACEUTICOS ACTIVOS CONTRA INFECCIONES BACTERIALES, QUE CONTIENEN DERIVADOS LIPOPEPTIDOS DE ESTE TIPO, PROCESO PARA LA ELABORACION DE DERIVADO LIPOPEPTIDO Y DE LOS PREPARADOS FARMACEUTICOS ASI COMO UTILIZACION DEL DERIVADO LIPOPEPTIDO PARA LA LUCHA CONTRA INFECCIONES BACTERIALES.
ES95104376T 1994-03-30 1995-03-24 Derivados lipopeptidos, procedimiento para su preparacion y su empleo. Expired - Lifetime ES2178657T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4411025A DE4411025A1 (de) 1994-03-30 1994-03-30 Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
ES2178657T3 true ES2178657T3 (es) 2003-01-01

Family

ID=6514230

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95104376T Expired - Lifetime ES2178657T3 (es) 1994-03-30 1995-03-24 Derivados lipopeptidos, procedimiento para su preparacion y su empleo.

Country Status (24)

Country Link
US (1) US5629288A (es)
EP (1) EP0688789B1 (es)
JP (1) JP3653119B2 (es)
KR (1) KR100360129B1 (es)
CN (1) CN1111640A (es)
AT (1) ATE219499T1 (es)
AU (1) AU696566B2 (es)
CA (1) CA2145826C (es)
CZ (1) CZ287158B6 (es)
DE (2) DE4411025A1 (es)
DK (1) DK0688789T3 (es)
ES (1) ES2178657T3 (es)
FI (1) FI951468L (es)
HU (1) HU218286B (es)
IL (1) IL113160A (es)
MA (1) MA23490A1 (es)
NO (1) NO951198L (es)
NZ (1) NZ270828A (es)
OA (1) OA10142A (es)
PL (1) PL180274B1 (es)
PT (1) PT688789E (es)
RU (1) RU2141970C1 (es)
TW (1) TW336939B (es)
ZA (1) ZA952555B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965524A (en) * 1989-07-07 1999-10-12 Peptide Technologies Corporation Analogs of viscosin and uses thereof
TW455591B (en) * 1993-06-08 2001-09-21 Hoechst Ag Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US7067500B2 (en) * 1997-05-02 2006-06-27 Integrated Research Technology, Llc Betaines as adjuvants to susceptibility testing and antimicrobial therapy
US6406880B1 (en) * 1997-05-02 2002-06-18 Integrated Research Technology, Llc Betaines as adjuvants to susceptibility testing and antimicrobial therapy
WO1999020651A1 (en) * 1997-10-21 1999-04-29 Sankyo Company, Limited Novel antifungal compounds
DE19807972A1 (de) * 1998-02-25 1999-08-26 Hoechst Marion Roussel De Gmbh Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung
WO2000063239A1 (en) * 1999-04-16 2000-10-26 Sankyo Company, Limited Novel antifungal compounds
AU784942B2 (en) * 1999-12-15 2006-08-03 Cubist Pharmaceuticals, Inc. Daptomycin analogs and their use as antibacterial agents
US6911525B2 (en) 1999-12-15 2005-06-28 Cubist Pharmaceuticals, Inc. Lipopeptides as antibacterial agents
JP2003517480A (ja) * 1999-12-15 2003-05-27 キュービスト ファーマシューティカルズ， インコーポレイテッド 抗菌剤としてのリポペプチド
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
WO2002005837A1 (en) * 2000-07-17 2002-01-24 Intrabiotics Pharmaceuticals, Inc. Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
US6750199B2 (en) 2000-07-17 2004-06-15 Micrologix Biotech Inc. Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
US6737403B2 (en) 2000-07-17 2004-05-18 Micrologix Biotech Inc. Derivatives of laspartomycin and preparation and use thereof
US6511962B1 (en) * 2000-07-17 2003-01-28 Micrologix Biotech Inc. Derivatives of laspartomycin and preparation and use thereof
US20030045484A1 (en) 2000-12-18 2003-03-06 Dennis Keith Methods for preparing purified daptomycin
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
EP1423414A4 (en) 2001-08-06 2005-11-30 Cubist Pharm Inc NEW DEPSIPEPTIDES AND METHOD FOR THE PRODUCTION THEREOF
WO2003057724A1 (en) 2002-01-03 2003-07-17 Micrologix Biotech Inc. Dab9 DERIVATIVES OF LIPOPEPTIDE ANTIBIOTICS AND METHODS OF MAKING AND USING THE SAME
EP1656390A2 (en) * 2003-07-17 2006-05-17 Migenix Inc. Compositions of lipopeptide antibiotic derivatives and methods of use thereof
US8420602B2 (en) * 2004-09-14 2013-04-16 Landon C. G. Miller Endocannabinoid conjugate and a pharmaceutical composition for treatment of neuronal disorders
DE102005056194A1 (de) * 2005-11-21 2007-07-12 Combinature Biopharm Ag Neue Lipopeptid Zusammensetzungen
US7795207B2 (en) 2005-11-21 2010-09-14 Harald Labischinski Lipopeptide compositions
US20080057047A1 (en) * 2005-11-29 2008-03-06 Benedikt Sas Use of bacillus amyloliquefaciens PB6 for the prophylaxis or treatment of gastrointestinal and immuno-related diseases
TWI409077B (zh) * 2006-04-18 2013-09-21 Piramal Life Sciences Ltd 新穎抗菌化合物
US7888940B2 (en) * 2007-02-19 2011-02-15 Schlumberger Technology Corporation Induction resistivity cover
GB0821540D0 (en) * 2008-11-25 2008-12-31 Merlion Pharmaceuticals Pte Ltd Lipopeptide compounds and their use
CN102325787B (zh) * 2008-12-22 2014-05-28 丘比斯特药物股份有限公司 治疗革兰氏阳性感染的新的抗菌剂
MX2012005993A (es) 2009-11-23 2012-11-23 Cubist Pharm Inc Composiciones de lipopeptido y metodos relacionados.
CN103554230B (zh) * 2013-09-18 2015-07-22 福建省微生物研究所 一种安福霉素类化合物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8005121A (nl) * 1979-09-20 1981-03-24 Erba Farmitalia Biologisch actieve peptiden.
CA1337758C (en) * 1988-04-11 1995-12-19 Eli Lilly And Company Peptide antibiotics
US5049546A (en) * 1990-03-19 1991-09-17 Merck & Co., Inc. Antibiotic agents
US5306708A (en) * 1990-12-19 1994-04-26 Merck & Co., Inc. Antibiotic agent
TW455591B (en) * 1993-06-08 2001-09-21 Hoechst Ag Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
FI951468A7 (fi) 1995-10-01
CZ287158B6 (en) 2000-10-11
PL307914A1 (en) 1995-10-02
FI951468A0 (fi) 1995-03-28
HUT71584A (en) 1995-12-28
KR950032636A (ko) 1995-12-22
EP0688789B1 (de) 2002-06-19
IL113160A (en) 1999-04-11
JPH07278186A (ja) 1995-10-24
OA10142A (fr) 1996-12-18
AU696566B2 (en) 1998-09-10
IL113160A0 (en) 1995-06-29
DK0688789T3 (da) 2002-10-14
DE4411025A1 (de) 1995-10-05
CA2145826C (en) 2008-01-08
HK1012017A1 (en) 1999-07-23
TW336939B (en) 1998-07-21
ZA952555B (en) 1995-12-21
ATE219499T1 (de) 2002-07-15
RU95106362A (ru) 1996-12-27
NO951198D0 (no) 1995-03-29
CZ77995A3 (en) 1995-10-18
US5629288A (en) 1997-05-13
PT688789E (pt) 2002-11-29
HU218286B (en) 2000-07-28
DE59510246D1 (de) 2002-07-25
AU1611095A (en) 1995-10-12
NZ270828A (en) 1996-10-28
CN1111640A (zh) 1995-11-15
PL180274B1 (pl) 2001-01-31
RU2141970C1 (ru) 1999-11-27
EP0688789A1 (de) 1995-12-27
NO951198L (no) 1995-10-02
MA23490A1 (fr) 1995-10-01
FI951468L (fi) 1995-10-01
CA2145826A1 (en) 1995-10-01
JP3653119B2 (ja) 2005-05-25
KR100360129B1 (ko) 2003-03-26

Similar Documents

Publication Publication Date Title
ES2178657T3 (es) Derivados lipopeptidos, procedimiento para su preparacion y su empleo.
ES2142798T3 (es) Derivados de 3-amido pirazol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2063146T3 (es) Composiciones farmaceuticas que contienen acido n-(3,4-dimetoxicinamoil)-antranilico.
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
ES2128791T3 (es) Derivados espirocetales, composiciones que los contienen y su uso como agentes terapeuticos.
CO4130326A1 (es) Nuevos derivados de 2-ciano-1,3-diona, composiciones que los contienen, procedimientos para su preparacion y su uso como herbicidas
AR005053A1 (es) Compuestos de difenilhexano, un procedimiento para su preparacion, composiciones farmaceuticas y el uso de dichos compuestos, y procedmientos para la manufactura de medicamentos para inhibir la infeccion de hiv
BR9714082A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto.
CO4130325A1 (es) Nuevos derivados herbicidas de 2-ciano-1,3-diona, procedi- mientos para su preparacion y composiciones que los contie- nen
ES2190469T3 (es) Derivados de isocumarina y su uso en farmacos.
ES2055860T3 (es) Derivados 2-aminopirimidinona.
BR9911482A (pt) Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto
ES2094539T3 (es) Preparacion farmaceutica y procedimiento para su preparacion.
PA8432901A1 (es) Compuestos de piridilpirrol
ES2171416T3 (es) Remedio contra la trombocitopenia.
NO924723D0 (no) Farmakologisk anvendelse av visse cystinderivater
ES2156120T3 (es) Derivados arilamidicos.
ES2126114T3 (es) Composiciones liquidas estables de interferon gamma.
SE8002322L (sv) Medel for behandling av inflammatoriska tarmsjukdomar
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
BR0010983A (pt) Preparações para a aplicação de agentes antiinflamatórios
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
ES2186900T3 (es) Compuestos de bromotiacumicina.
IL99471A0 (en) Pharmaceutical compositions containing pyridylmethylsulphinyl-1h-benzimidazole derivatives as active ingredient therein
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.